These two ASX shares couldn’t be more different, yet both make sense to me heading into 2026. The post Why I think CSL and ...

The 1971 BMW 3.0 CSL did not begin life as a collector’s darling or a design statement. It was conceived as a blunt ...

Ord Minnett analyst maintained a Hold rating on CSL today and set a price target of A$217.00. CMXHF market cap is currently A$83.67B and has a P/E ratio of 18.01. Based on the recent corporate insider ...

CSL Ltd (ASX: CSL) shares slumped in 2025, but the outlook may be improving. Here’s why I think CSL could beat the ASX 200 ...

BMW has brought back the 3.0 CSL name on a new limited-edition sports car that echoes the design of the original '70s-era 3.0 CSL and sports a motorsports-inspired livery. The twin-turbo 3.0-liter ...

Steven Ewing spent his childhood reading car magazines, making his career as an automotive journalist an absolute dream job. After getting his foot in the door at Automobile while he was still a ...

CSL Ltd (ASX: CSL) shares were sold off in 2025. Let's find out why and see if this is a buying opportunity for ...

CSL Limited, a biotechnology company that produce many of its biological products from plasma, is diversifying its portfolio and its drug pipeline through its largest ever acquisition: the purchase of ...

In an effort to drum up hype for its newly released M4 CSL, BMW is revealing a bunch of never-before-seen CSL concepts to the public. Earlier this week it showed off a V-8-powered M3 CSL alongside the ...

CSL Behring’s largest-ever trial has ended in failure, as the Australian pharma revealed that its cholesterol efflux enhancer was unable to reduce the risk of heart attacks. The company had been ...